Scientists have developed a proof-of-concept vaccine that could offer broad protection against all known and emerging variants of highly pathogenic avian influenza (A5) viruses, including those that have yet to evolve.
The one-shot vaccine, described in the journal Nature, could significantly strengthen defences against the threat of a future pandemic.
Mathilde Rochard of Erasmus University Medical Centre in the Netherlands and her team created a high-resolution 3D map showing how the H5 haemagglutinin (HA) protein has changed over decades. The map revealed the full evolutionary history and diversity of H5 strains.
Using this map, the researchers designed a synthetic HA protein that sits at the antigenic centre of all known H5 variants. Although not an exact match for every strain, it is the closest to all existing and potential future viruses. By exposing the immune system to this central antigen, the vaccine aims to trigger a broad antibody response capable of fighting a wide range of H5 infections.
Tests in ferrets, a common model for influenza studies, showed that the vaccine provided strong protection against multiple, distinct H5 strains, comparable to strain-specific vaccines, and even against two viruses not included in the formulation.
While the findings are promising, the researchers cautioned that human trials are still needed to confirm the vaccine’s safety and effectiveness.
From Emirates 24/7
Sleep, physical activity and diet are key lifestyle behaviours that influence the risk of cardiovascular disease and…
Not long after Leonardo DiCaprio walked the red carpet as a Best Actor nominee at…
Research increasingly shows that everyday lifestyle choices, including diet, play an important role in preserving…
The United States said on Wednesday its military had completely halted trade going in and…
Pope Leo said he did not fear the Trump administration and would continue to speak…
Pope Leo XIV has arrived in Algeria for the first papal visit to the country,…